LIMS2 and neoplasm: To validate the expression levels of the eight key genes (LIMS2, TP53INP2, IRAK3, STX2, CYP27A1, IL11RA, KCNMB1, and PDLIM7) in tumor and non-tumor samples, we analyzed their expression in TCGA and GSE7476 datasets.